Research Interests

• Our research aims at promoting the standardized diagnosis and treatment of Parkinson's disease(PD)  and developing new symptomatic treatments for Levodopa induced dyskinesia(LID). We utilize multiple methodologies to address it at multiple levels. We conduct the multicenter clinical research to evaluate the efficacy of certain treatment for PD. Moreover, we explore the synaptic and circuit mechanisms that drive the development of LID using cut-edge methods. We have undertaken 29 scientific projects, including 1 project supported by National key R&D Program of China, 5 projects supported by National Science Foundation of China. Our team has published more than 300 papers including 93 SCI papers.